Management of Macrocytic Anemia in a 69-Year-Old Patient
Immediate Diagnostic Workup Required
Your patient has macrocytic anemia (MCV 104 fL, MCH 35.2 pg, hemoglobin 14.1 g/dL) that requires immediate evaluation for vitamin B12 and folate deficiency before any treatment is initiated. 1, 2
Essential First-Line Laboratory Tests
- Serum vitamin B12 level (deficiency defined as <150 pmol/L or <203 ng/L) 2, 3
- Serum folate and RBC folate levels (deficiency: serum folate <10 nmol/L or RBC folate <305 nmol/L) 2, 3
- Reticulocyte count to differentiate between deficiency states versus hemolysis or bleeding response 1, 3
- Thyroid-stimulating hormone (TSH) to exclude hypothyroidism as a cause 2
- Methylmalonic acid if B12 level is borderline (>271 nmol/L confirms deficiency) 2
Additional Tests to Identify Coexisting Deficiencies
- Serum ferritin and transferrin saturation to identify concurrent iron deficiency, which can mask macrocytosis 1, 2, 3
- Red cell distribution width (RDW) - an elevated RDW suggests coexisting iron deficiency even when MCV is elevated 2
- Haptoglobin and LDH if reticulocytes are elevated to assess for hemolysis 1, 3
Your patient's RDW is normal (12.1%), making coexisting iron deficiency less likely, but ferritin should still be checked. 2
Treatment Algorithm Based on Etiology
If Vitamin B12 Deficiency is Confirmed
Critical: Always exclude and treat vitamin B12 deficiency BEFORE initiating folate supplementation, as folate can mask B12 depletion and allow irreversible neurological damage to progress. 1, 2, 3
For B12 Deficiency WITHOUT Neurological Symptoms:
- Hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks 1, 2
- Followed by maintenance: 1 mg intramuscularly every 2-3 months for life 1, 2, 4
For B12 Deficiency WITH Neurological Symptoms:
- Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement 1, 2
- Then 1 mg intramuscularly every 2 months for life 1, 2
If Folate Deficiency is Confirmed (After Excluding B12 Deficiency)
If Myelodysplastic Syndrome (MDS) is Diagnosed
- Lenalidomide for patients with del(5q) cytogenetic abnormality 1, 3
- Erythropoietin therapy for patients with normal cytogenetics, <15% marrow ringed sideroblasts, and serum erythropoietin ≤500 mU/mL 3
- Add G-CSF if no response to erythropoietin alone 1, 3
- Verify iron repletion before starting erythropoietin therapy 3
Monitoring Response to Treatment
- Serial monitoring of MCV, MCH, hemoglobin, and reticulocyte count every 2-4 weeks initially 1, 3
- An increase in hemoglobin of at least 2 g/dL within 4 weeks indicates acceptable response 2
- Reticulocyte response should be observed within 1 week of appropriate vitamin replacement 4
Mandatory Hematology Referral Criteria
Refer immediately to hematology if: 1, 3
- Cause remains unclear after complete workup
- Suspicion for myelodysplastic syndrome (especially with leucopenia or thrombocytopenia)
- Hemolytic anemia is confirmed
- Pancytopenia is present
- No response to appropriate vitamin replacement after 2-3 weeks
Common Causes to Consider in This Patient
The most common causes of macrocytosis in hospitalized patients are medications, alcohol use, liver disease, and reticulocytosis, with megaloblastic anemia (B12/folate deficiency) accounting for less than 10% of cases. 5 However, MCV values >100 fL warrant investigation for vitamin deficiency regardless of prevalence. 6, 5
Medication Review
Your patient should be evaluated for medications causing macrocytosis, including: 1, 2
- Anticonvulsants
- Methotrexate
- Azathioprine or 6-mercaptopurine
- Hydroxyurea
- Sulfasalazine
Alcohol Use Assessment
Chronic alcohol use causes macrocytosis independent of nutritional deficiencies and may impair B12 absorption. 2, 6, 7
Critical Pitfalls to Avoid
- Never treat folate deficiency before excluding B12 deficiency - this can precipitate subacute combined degeneration of the spinal cord 1, 2, 3
- Do not overlook coexisting iron deficiency - mixed deficiencies require treatment of both simultaneously 3
- Do not assume normal hemoglobin excludes significant pathology - macrocytosis is not related to hemoglobin concentration and may be the only indicator of vitamin deficiency, preleukemia, or alcoholism 6
Management of Other Laboratory Abnormalities
Hypercholesterolemia (Total Cholesterol 210 mg/dL)
Your patient's LDL is 98 mg/dL (borderline), HDL is excellent at 98 mg/dL, and triglycerides are normal. The LDL/HDL ratio of 1.0 is favorable. This does not require immediate pharmacologic intervention but warrants lifestyle modification counseling.
Low BUN (6 mg/dL)
This isolated finding with normal creatinine (eGFR 94 mL/min/1.73) likely reflects adequate hydration or low protein intake and does not require specific treatment in the absence of other symptoms.